PROK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Prokidney Corp (PROK) is not a strong buy for a beginner, long-term investor at this moment. Despite a significant revenue increase, the company's financials show declining net income and EPS, and insider selling has surged significantly. Additionally, technical indicators are neutral, and there is no strong positive sentiment from options or trading signals. The lack of recent news or influential figure activity further limits the case for an immediate buy.
The MACD is slightly positive at 0.0305, but contracting, indicating weakening momentum. RSI is neutral at 48.146, and moving averages are converging, showing no clear trend. Key support and resistance levels are close to the current price, with a pivot at 2.018. Overall, the technical indicators suggest a neutral trend.
Revenue increased significantly by 196.05% YoY in Q4 2025, showing strong top-line growth. Gross margin remains at 100%, which is a positive sign for operational efficiency.
Insider selling has surged by 503.05% in the last month, indicating a lack of confidence from internal stakeholders. Net income and EPS have declined, with net income dropping by -9.62% YoY and EPS falling by -17.65% YoY. No recent news or influential figure activity to drive positive sentiment.
In Q4 2025, revenue grew significantly by 196.05% YoY to $225,000. However, net income dropped to -$19,231,000 (-9.62% YoY), and EPS fell to -0.14 (-17.65% YoY). Gross margin remained stable at 100%. While revenue growth is strong, profitability metrics are deteriorating.
No recent analyst ratings or price target changes are available for PROK.
